InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Lubner David Charles, Director. Director active across 4 companies, notably Arcellx, Inc.. Cumulatively, 8 filings have been logged. Breakdown: 2 buys · 1 sell. Total volume traded: €1.3m. History available since 8 February 2022. The latest transaction was filed on 7 August 2026 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Lubner David Charles
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
55,555 shares@ US$18.00Common StockSEC:0001470831-26-000796:0
Canonical exit: 5 Nov 2026 (T+90)
53,625 shares0Common StockSEC:0001193125-26-187601:0
21,659 sharesCommon StockSEC:0001572000-26-000002:0
6,000 shares@ US$6.287.7% of flowCommon StockSEC:0001193125-26-017002:0
6,000 shares@ US$75.0092.3% of flowCommon StockSEC:0001193125-26-017002:1
35,400 sharesCommon StockSEC:0001104659-23-129769:0
3,600 shares@ US$6.85100.0% of flowCommon StockSEC:0001104659-22-122395:0
Canonical exit: 21 Feb 2023 (T+90)
21,659 shares0Common StockSEC:0001209191-22-008159:0
8 of 8 declarations
About Lubner David Charles
David Charles Lubner is a Director at Arcellx, Inc., a biotechnology company. As a director, he participates in the governance of the company and in strategic decision-making. His experience in the biotechnology field is an asset for Arcellx.
